Incyte Biosciences Canada Corporation
| Specific Topics of Lobbying Communications | Intended Outcomes | Associated Subject Matters |
|---|---|---|
|
Advocacy regarding changes to how innovative therapies are made accessible to patients residing in British Columbia.
|
Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation, Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Children and Families, Health, Hospitals, Indigenous Relations and Reconciliation, Industry
|
|
Discuss innovative agreements for reimbursement and the use of RWE in evaluation of pharmaceutical products.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity, Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
|
Finances and Budgets, Health, Hospitals, Science and Technology, Senior Citizens
|
|
Educate government stakeholders about life-science strategies and policies that impact access to innovative medicines.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Economic Development and Trade, Finances and Budgets, Health, Hospitals, Senior Citizens
|
|
Educate on the unmet needs of rare cancers and how to facilitate improved processes within the government to allow for innovation in rare diseases.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Health, Hospitals, Science and Technology
|
|
Explain the need for expanded Next Generation Sequencing tests in order to provide innovative personalized cancer care to BC patients.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Health, Hospitals, Science and Technology
|
|
Identify changes to pharmaceutical legislation supporting appropriate government reimbursement of medicines.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity, Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
|
Health, Hospitals, Science and Technology, Senior Citizens
|
|
Raise awareness of the value that innovative medicines provide and demonstrate that Incyte Biosciences Canada supports the growth of the life-science sector in BC.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Economic Development and Trade, Health, Hospitals, Science and Technology
|